Xiangyu Medical(SH:688626) Xin Lang Zheng Quan·2025-10-30 03:37Core Viewpoint - Xiangyu Medical's stock has shown significant growth this year, with an 88.35% increase, reflecting strong market interest and performance in the rehabilitation medical device sector [1][2]. Financial Performance - For the first half of 2025, Xiangyu Medical reported revenue of 359 million yuan, a year-on-year increase of 6.27%, while net profit attributable to shareholders decreased by 37.50% to 35.39 million yuan [2]. - The company has distributed a total of 277 million yuan in dividends since its A-share listing, with 157 million yuan distributed over the past three years [3]. Stock Market Activity - As of October 30, the stock price reached 54.92 yuan per share, with a market capitalization of 8.787 billion yuan. The stock has seen a trading volume of 83.32 million yuan and a turnover rate of 0.96% [1]. - The stock has experienced a net inflow of 3.06 million yuan from main funds, with significant buying activity from large orders [1]. Shareholder Information - As of June 30, the number of shareholders increased by 6.90% to 6,302, while the average number of circulating shares per person decreased by 6.46% to 25,388 shares [2]. - Hong Kong Central Clearing Limited is noted as a new major shareholder, holding 793,300 shares [3]. Business Overview - Xiangyu Medical, established in March 2002 and listed in March 2021, specializes in the research, production, and sales of rehabilitation medical devices. The revenue composition includes 67.79% from rehabilitation therapy equipment, 22.13% from rehabilitation training equipment, and smaller percentages from other categories [1][2].